Amrix Capsule, Extended Release
Product Images NDC 63459-700

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amrix (NDC 63459-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cephalon, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

FDA Label Image

Image 2

FDA Label Image

Image 3

FDA Label Image

Image 4

FDA Label Image

Image 5

FDA Label Image

Image 6

FDA Label Image

Image 7

FDA Label Image

Image 8

Image 8
Each capsule of this medication contains 15mg of cyclobenzaprine hydrochloride. It is an extended-release capsule that needs to be taken once daily at the same time. It is recommended for adults to take one or two capsules. For further information, refer to the package insert. It is important to keep this medication out of reach of children and away from freezing temperatures. This medication is available only with a prescription. Lot/Exp coding area is present on the packaging.*
FDA Label Image

Image 9

Image 9
Each extended-release capsule contains 30mg of cyclobenzaprine hydrochloride. The recommended dosage for adults is one capsule taken once daily at approximately the same time each day. For additional information, refer to the package insert. This medication should be kept out of the reach of children. The lot/exp coding area is for Rx only. The text also includes NDC and Rev details. The medication is an extended-release capsule. The text appears to be related to the medication Cyclobenzaprine Hydrochloride.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.